Traders may want to take interest in holdings disclosed by Sabby Management LLC to the SEC on Thursday.
The firm reported 9.99 percent ownership stakes in the following biotech companies:
Neurometrix Inc NURO is a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes.
Arca Biopharma Inc ABIO is a biopharmaceutical company focused on developing genetically-targeted therapies for heart failure and other cardiovascular diseases.
OXiGENE Inc OXGN is a biopharmaceutical company developing therapeutics primarily to treat cancer.
Arca Biopharma moved sharply Friday, recently trading at $0.850, down 4.49 percent.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
